Artificial Tears Suppliers & Bulk Manufacturers
Available Forms: Eye Drops/ Eye Gel/ Eye ointment
Available Strengths: 0.3% to 1%
Reference Brands: Refresh Tears (USA/LATAM), Hylo-Tear (EU), Refresh Liquigel (India)
Category:
Opthalmology
Artificial Tears is available in Eye Drops/ Eye Gel/ Eye ointment
and strengths such as 0.3% to 1%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Artificial Tears is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Artificial Tears can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Artificial tears are widely used as the primary treatment for dry eye disease and play an important role in maintaining ocular surface health. These ophthalmic lubricants help restore moisture to the eyes, reduce irritation, and improve tear film stability. In addition to dry eye management, artificial tears are also used in conditions such as corneal abrasions, minor eye injuries, conjunctivitis, keratitis, and for contact lens rewetting or removal. They can also assist in flushing out small foreign particles from the eye and supporting the natural healing process of the corneal surface.
Clinical evidence from multiple randomized controlled studies shows that regular use of artificial tears can significantly improve the symptoms of dry eye disease, often within about one month when applied several times daily. However, visible improvement in clinical signs may take longer, sometimes several months. Not every patient responds equally to artificial tears, and if noticeable relief is not achieved after consistent use for a few weeks, alternative or additional treatment options may be recommended.
Research also suggests that combination formulations containing multiple lubricating agents may provide better relief compared to single-ingredient products. Certain formulations, particularly those containing polyethylene glycol or lipid-based components, may be more effective for specific types of dry eye, including evaporative dry eye disease.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing